FDA Inspection 1172209 — Reproductive Medicine Associates Of Philadelphia
The FDA completed an inspection of Reproductive Medicine Associates Of Philadelphia on Jun 10, 2022 in King of Prussia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 10, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- King of Prussia, PA (United States)